Mereo BioPharma (MREO) Non Operating Investment Income (2023 - 2026)
Mereo BioPharma (MREO) reported Non Operating Investment Income of $17000.0 for Q1 2026, down 95.91% year-over-year from $416000.0 in Q1 2025, and down 94.22% quarter-over-quarter from $294000.0 in Q4 2025.
Mereo BioPharma (MREO) Non Operating Investment Income (2023 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has 4 years of Non Operating Investment Income data on file, last reported at $17000.0 in Q1 2026.
- Non Operating Investment Income for Q1 2026 came in at $17000.0, down 95.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $406000.0 (down 8.76% YoY), and the FY2025 annual result was $805000.0, up 292.12% from the prior year.
- Non Operating Investment Income declined to $17000.0 in Q1 2026 per MREO's latest filing, from $294000.0 in the prior quarter.
- Over five years, Non Operating Investment Income peaked at $542000.0 in Q1 2023 and troughed at -$448000.0 in Q1 2024.
- A 4-year average of $54000.0 and a median of -$21000.0 in 2024 frame the typical range for Non Operating Investment Income.
- The sharpest annual moves came in 2024 and 2025: Non Operating Investment Income plunged 182.66% in 2024, then surged 432.2% in 2025.
- A 4-year view of Non Operating Investment Income shows it stood at -$195000.0 in 2023, then jumped by 180.51% to $157000.0 in 2024, then surged by 87.26% to $294000.0 in 2025, then sank by 94.22% to $17000.0 in 2026.
- Business Quant data shows MREO's Non Operating Investment Income at $17000.0 in Q1 2026, $294000.0 in Q4 2025, and $196000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 235,807.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 230,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mereo BioPharma | 252.49 Mn | 252.49 Mn | - | 17,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17,000.00 |
| Mar 31, 2026 | 17,000.00 |
| Dec 31, 2025 | 294,000.00 |
| Dec 31, 2025 | 294,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Sep 30, 2025 | 196,000.00 |
| Jun 30, 2025 | -101,000.00 |
| Jun 30, 2025 | -101,000.00 |
| Mar 31, 2025 | 416,000.00 |
| Mar 31, 2025 | 416,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Dec 31, 2024 | 157,000.00 |
| Sep 30, 2024 | -59,000.00 |
| Sep 30, 2024 | -59,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Jun 30, 2024 | -69,000.00 |
| Mar 31, 2024 | -448,000.00 |
| Mar 31, 2024 | -448,000.00 |
| Dec 31, 2023 | -195,000.00 |
| Dec 31, 2023 | -195,000.00 |